Article ID Journal Published Year Pages File Type
5951663 Atherosclerosis 2008 7 Pages PDF
Abstract
Greater reduction in platelet activity observed with rosiglitazone may be related to reduced oxidative stress and a possible direct PPARγ mediated effect on platelet function.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus-An effect probably mediated by direct platelet PPARγ activation
Authors
, , , , , , , ,